Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Perfetti, Alessandra ^a   Greco, Simona ^a   Fasanaro, Pasquale ^b   Bugiardini, Enrico ^c   Cardani, Rosanna ^a   Garcia Manteiga, Jose M ^d   Riba, Michela ^d   Cittaro, Davide ^d   Stupka, Elia ^d   Meola, Giovanni ^a,c   Martelli, Fabio ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; FETOPROTEIN; FHOD1 PROTEIN, HUMAN; LDB3 PROTEIN, HUMAN; LIM PROTEIN; MAPT PROTEIN, HUMAN; MBNL1 PROTEIN, HUMAN; NFIX PROTEIN, HUMAN; NUCLEAR FACTOR I; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOINFORMATICS; CALCIUM SIGNALING; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; MUSCLE CONTRACTILITY; MUSCLE METABOLISM; MYOTONIC DYSTROPHY; POLYMERASE CHAIN REACTION; RNA ANALYSIS; BIOLOGY; BIOPSY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; MALE; METABOLISM; MIDDLE AGED; SKELETAL MUSCLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALTERNATIVE SPLICING; BIOPSY; CALCIUM SIGNALING; CELL SURVIVAL; COMPUTATIONAL BIOLOGY; EXONS; FEMALE; FETAL PROTEINS; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; LIM DOMAIN PROTEINS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; NFI TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RNA; RNA-BINDING PROTEINS; TAU PROTEINS;

EID: 84899498641     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093983     Document Type: Article

References (68)

1. Harper PS, van Engelen BG, Eymard B, Rogers M, Wilcox D (2002) 99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands. Neuromuscul Disord 12: 596-599. (Pubitemid 34756835)
2. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 69: 385.
3. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, et al. (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258.
4. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255: 1253-1255.
5. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864-867. (Pubitemid 32743976)
6. Wojciechowska M, Krzyzosiak WJ (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20: 3811-3821.
7. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, et al. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11: 805-814. (Pubitemid 34428648)
8. Osborne RJ, Thornton CA (2006) RNA-dominant diseases. Hum Mol Genet 15 Spec No 2: R162-169. (Pubitemid 44446789)
9. Fernandez-Costa JM, Llamusi MB, Garcia-Lopez A, Artero R (2011) Alternative splicing regulation by Muscleblind proteins: from development to disease. Biol Rev Camb Philos Soc 86: 947-958.
10. Klein AF, Gasnier E, Furling D (2011) Gain of RNA function in pathological cases: Focus on myotonic dystrophy. Biochimie 93: 2006-2012.
11. Sicot G, Gourdon G, Gomes-Pereira M (2011) Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges. Hum Mol Genet 20: R116-123.
12. Ranum LP, Day JW (2004) Pathogenic RNA repeats: an expanding role in genetic disease. Trends Genet 20: 506-512. (Pubitemid 39201071)
13. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413-1415.
14. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476. (Pubitemid 352759009)
15. Blekhman R, Marioni JC, Zumbo P, Stephens M, Gilad Y (2010) Sex-specific and lineage-specific alternative splicing in primates. Genome Res 20: 180-189.
16. Stetefeld J, Ruegg MA (2005) Structural and functional diversity generated by alternative mRNA splicing. Trends Biochem Sci 30: 515-521. (Pubitemid 41206507)
17. Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, et al. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15: 2087-2097. (Pubitemid 43923398)
18. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, et al. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel premRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 10: 35-44. (Pubitemid 34879147)
19. Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29: 40-47. (Pubitemid 32801806)
20. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, et al. (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74: 1309-1313. (Pubitemid 38669332)
21. Vihola A, Bachinski LL, Sirito M, Olufemi SE, Hajibashi S, et al. (2010) Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. Acta Neuropathol 119: 465-479.
22. Vihola A, Sirito M, Bachinski LL, Raheem O, Screen M, et al. (2013) Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2. Neuropathol Appl Neurobiol 39: 390-405.
23. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, et al. (2003) A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980. (Pubitemid 37523508)
24. Buj-Bello A, Furling D, Tronchere H, Laporte J, Lerouge T, et al. (2002) Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet 11: 2297-2307.
25. Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, et al. (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2 +-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14: 2189-2200. (Pubitemid 41418018)
26. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193.
27. Nakamori M, Sobczak K, Puwanant A, Welle S, Eichinger K, et al. (2013) Splicing biomarkers of disease severity in myotonic dystrophy. Ann Neurol.
28. Bachinski LL, Baggerly KA, Neubauer VL, Nixon TJ, Raheem O, et al. (2013) Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord.
29. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, et al. (2011) Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands. Neuromuscul Disord 21: 443-450.
30. Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G (2004) Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48: 437-442.
31. Greco S, Perfetti A, Fasanaro P, Cardani R, Capogrossi MC, et al. (2012) Deregulated microRNAs in myotonic dystrophy type 2. PLoS One 7: e39732.
32. Geller SC, Gregg JP, Hagerman P, Rocke DM (2003) Transformation and normalization of oligonucleotide microarray data. Bioinformatics 19: 1817-1823. (Pubitemid 37220474)
33. Weigand JE, Boeckel JN, Gellert P, Dimmeler S (2012) Hypoxia-induced alternative splicing in endothelial cells. PLoS One 7: e42697.
34. Clark TA, Schweitzer AC, Chen TX, Staples MK, Lu G, et al. (2007) Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8: R64.
35. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
36. Smyth GK (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor, R . Gentleman, V . Carey, S . Dudoit, R . Irizarry, W . Huber (eds): 397-420.
37. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300.
38. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
39. Sugnet CW, Kent WJ, Ares M Jr, Haussler D (2004) Transcriptome and genome conservation of alternative splicing events in humans and mice. Pac Symp Biocomput: 66-77.
40. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13: 3079-3088. (Pubitemid 40045262)
41. Ohsawa N, Koebis M, Suo S, Nishino I, Ishiura S (2011) Alternative splicing of PDLIM3/ALP, for alpha-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy. Biochem Biophys Res Commun 409: 64-69.
42. Fugier C, Klein AF, Hammer C, Vassilopoulos S, Ivarsson Y, et al. (2011) Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy. Nat Med 17: 720-725.
43. Koebis M, Ohsawa N, Kino Y, Sasagawa N, Nishino I, et al. (2011) Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1. Genes Cells 16: 961-972.
44. Tang ZZ, Yarotskyy V, Wei L, Sobczak K, Nakamori M, et al. (2012) Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet 21: 1312-1324.
45. Santoro M, Masciullo M, Bonvissuto D, Bianchi ML, Michetti F, et al. (2013) Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2. Mol Cell Biochem 380: 259-265.
46. Charlet BN, Savkur RS, Singh G, Philips AV, Grice EA, et al. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-53. (Pubitemid 34879148)
47. Ursu SF, Alekov A, Mao NH, Jurkat-Rott K (2012) ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro. Acta Myol 31: 144-153.
48. Kim YO, Oh IU, Park HS, Jeng J, Song BJ, et al. (1995) Characterization of a cDNA clone for human NAD(+)-specific isocitrate dehydrogenase alpha-subunit and structural comparison with its isoenzymes from different species. Biochem J 308 (Pt 1): 63-68.
49. Soundar S, Park JH, Huh TL, Colman RF (2003) Evaluation by mutagenesis of the importance of 3 arginines in alpha, beta, and gamma subunits of human NAD-dependent isocitrate dehydrogenase. J Biol Chem 278: 52146-52153. (Pubitemid 38035801)
50. Rusconi F, Mancinelli E, Colombo G, Cardani R, Da Riva L, et al. (2010) Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways. Neurobiol Dis 38: 273-280.
51. Gomes-Pereira M, Cooper TA, Gourdon G (2011) Myotonic dystrophy mouse models: towards rational therapy development. Trends Mol Med 17: 506-517.
52. Jansen G, Groenen PJ, Bachner D, Jap PH, Coerwinkel M, et al. (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 13: 316-324. (Pubitemid 26230498)
53. Harmon EB, Harmon ML, Larsen TD, Yang J, Glasford JW, et al. (2011) Myotonic dystrophy protein kinase is critical for nuclear envelope integrity. J Biol Chem 286: 40296-40306.
54. Leung T, Chen XQ, Tan I, Manser E, Lim L (1998) Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization. Mol Cell Biol 18: 130-140. (Pubitemid 28021025)
55. Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, et al. (2012) Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75: 437-450.
56. Ranum LP, Cooper TA (2006) RNA-mediated neuromuscular disorders. Annu Rev Neurosci 29: 259-277. (Pubitemid 44476846)
57. Timchenko L (2013) Molecular mechanisms of muscle atrophy in myotonic dystrophies. Int J Biochem Cell Biol 45: 2280-2287.
58. Pomies P, Pashmforoush M, Vegezzi C, Chien KR, Auffray C, et al. (2007) The cytoskeleton-associated PDZ-LIM protein, ALP, acts on serum response factor activity to regulate muscle differentiation. Mol Biol Cell 18: 1723-1733. (Pubitemid 46717554)
59. McKeown CR, Han HF, Beckerle MC (2006) Molecular characterization of the Caenorhabditis elegans ALP/Enigma gene alp-1. Dev Dyn 235: 530-538. (Pubitemid 43100959)
60. Udd B, Krahe R (2012) The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 11: 891-905.
61. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, et al. (2009) Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet 18: 1471-1481.
62. Schulman H, Hanson PI, Meyer T (1992) Decoding calcium signals by multifunctional CaM kinase. Cell Calcium 13: 401-411.
63. Braun AP, Schulman H (1995) The multifunctional calcium/calmodulin- dependent protein kinase: from form to function. Annu Rev Physiol 57: 417-445.
64. Hudmon A, Schulman H (2002) Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J 364: 593-611. (Pubitemid 34680833)
65. Singer HA, Benscoter HA, Schworer CM (1997) Novel Ca2+/calmodulin- dependent protein kinase II gamma-subunit variants expressed in vascular smooth muscle, brain, and cardiomyocytes. J Biol Chem 272: 9393-9400. (Pubitemid 27154953)
66. Tombes RM, Krystal GW (1997) Identification of novel human tumor cell-specific CaMK-II variants. Biochim Biophys Acta 1355: 281-292. (Pubitemid 27091384)
67. Nghiem P, Saati SM, Martens CL, Gardner P, Schulman H (1993) Cloning and analysis of two new isoforms of multifunctional Ca2+/calmodulin-dependent protein kinase. Expression in multiple human tissues. J Biol Chem 268: 5471-5479. (Pubitemid 23090865)
68. Kwiatkowski AP, McGill JM (2000) Alternative splice variant of gamma-calmodulin-dependent protein kinase II alters activation by calmodulin. Arch Biochem Biophys 378: 377-383. (Pubitemid 30397638)